An Observational Study of Patients With Malignant Lymphomas Treated With MabThera SC in Everyday Clinical Practice.

Trial Profile

An Observational Study of Patients With Malignant Lymphomas Treated With MabThera SC in Everyday Clinical Practice.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Rituximab (Primary)
  • Indications Diffuse large B cell lymphoma; Follicular lymphoma; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 04 Nov 2016 Planned End Date changed from 1 Dec 2018 to 1 Jul 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top